Showing 951-960 of 1560 results for "".
- Emerging Insights into HTLV-1 Persistence and Therapeutic Advanceshttps://reachmd.com/news/emerging-insights-into-htlv-1-persistence-and-therapeutic-advances/2476004/Human T-cell leukemia virus type 1 (HTLV-1) persistence hinges on its capacity to enter latency, evading immune detection and complicating efforts to eradicate infected cells. Recent discoveries reveal a
- A New Frontier in Ocular Neuroprotection: The Citicoline and Coenzyme Q10 Duohttps://reachmd.com/news/a-new-frontier-in-ocular-neuroprotection-the-citicoline-and-coenzyme-q10-duo/2474549/Emerging evidence suggests that combining Citicoline and Coenzyme Q10 offers a promising neuroprotective approach in managing ocular hypertension, potentially mitigating retinal ganglion cell loss. Preventing retinal ganglion cell dege
- Gut-Immune Interactions in Rheumatoid Arthritis: New Insightshttps://reachmd.com/news/gut-immune-interactions-in-rheumatoid-arthritis-new-insights/2474563/Recent research highlights the intricate role of gut immune cells in the progression of autoimmune diseases, particularly rheumatoid arthritis (RA). These findings suggest that interactions between gut microbiota and immune cells may exacerbate systemic inflammation, offeri
- Targeting GlycoRNAs in Cancer: Emerging Therapeutic Approacheshttps://reachmd.com/news/targeting-glycornas-in-cancer-emerging-therapeutic-approaches/2474298/Advancements in oncology have discovered that cell surface glycoRNAs associate with RNA-binding proteins, forming distinctive complexes that create new epitopes. These epitopes crucially impact cell signaling, survival, and metastasis.
- Harnessing Natural Ingredients: Gluconolactone’s Promise in Lupus Therapyhttps://reachmd.com/news/harnessing-natural-ingredients-gluconolactones-promise-in-lupus-therapy/2471606/Recent evidence demonstrates that gluconolactone enhances regulatory T cell differentiation and function while reducing TH17 cell activity, leading to decreased inflammation in lupus. This breakthrough may pave the way for integrating targeted natural therapies int
- Artificial Lymphoid Organs Could Help Predict Efficacy of Booster Vaccineshttps://reachmd.com/news/artificial-lymphoid-organs-could-help-predict-efficacy-of-booster-vaccines/2468108/After exposing the lymphoid organ-chips to viral proteins, activated T cells (purple) and B cells (blue) cluster together to promote antibody production, just as they do in real lymphoid
- Exploring Huntington's Disease: Researchers Discover That Protein Aggregates Poke Holes in the Nuclear Membranehttps://reachmd.com/news/exploring-huntingtons-disease-researchers-discover-that-protein-aggregates-poke-holes-in-the-nuclear-membrane/2467836/Expansion microscopy reveals the structure of huntingtin aggregates inside the cell nucleus. Credit: 2024 Korsten et al. Originally published in Journal of Cell Biology. 10.1083/jcb.2
- The Role of Diet in Modulating Cardiovascular Gene Activityhttps://reachmd.com/news/the-role-of-diet-in-modulating-cardiovascular-gene-activity/2484543/A controlled trial found that daily consumption of 100% orange juice for two months altered immune-cell transcriptomes linked to cardiovas
- EBV's Role in Lupus Pathogenesis: Insights from Stanford Researchhttps://reachmd.com/news/ebvs-role-in-lupus-pathogenesis-insights-from-stanford-research/2484465/A Stanford-led study demonstrates that Epstein-Barr virus (EBV) infection reprograms B cells into a defined driver phenoty
- Unveiling FGD3: A New Ally in the Fight Against Breast Cancerhttps://reachmd.com/news/unveiling-fgd3-a-new-ally-in-the-fight-against-breast-cancer/2484466/FGD3 sensitizes breast tumors to chemotherapy and immunotherapy in preclinical models by triggering cancer-cell swelling and membrane rupture